Chinese pharmaceutical company seeks partnership on endocrine, cardio-cerebrovascular, ocular, autoimmune diseases and tumor related drugs under license agreement

This Chinese pharmaceutical company has cooperation with many domestic pharmaceutical companies and industry funds. It has a mature platform for the R&D and production of macromolecule and small-molecule drugs. It is seeking innovative drugs in endocrine, cardio-cerebrovascular, ocular and autoimmune diseases and tumors. Those drugs can either be large-molecule, or small-molecule, or cell therapy drugs from Europe. Ideal cooperation could be via license agreement.